Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP308867.RAd8ookVKkZ6ryCNFBUcAIsphbo_cHNIOhWxATIf7J3sY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP308867.RAd8ookVKkZ6ryCNFBUcAIsphbo_cHNIOhWxATIf7J3sY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP308867.RAd8ookVKkZ6ryCNFBUcAIsphbo_cHNIOhWxATIf7J3sY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP308867.RAd8ookVKkZ6ryCNFBUcAIsphbo_cHNIOhWxATIf7J3sY130_provenance.
- NP308867.RAd8ookVKkZ6ryCNFBUcAIsphbo_cHNIOhWxATIf7J3sY130_assertion description "[Recently, recombinant factor VIIa concentrate has become available to treat hemophilia patients with inhibitor and factor VII deficiency patients in Europe and also recombinant factor IX for the treatment of hemophilia B has been licensed in the United States and Europe.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP308867.RAd8ookVKkZ6ryCNFBUcAIsphbo_cHNIOhWxATIf7J3sY130_provenance.
- NP308867.RAd8ookVKkZ6ryCNFBUcAIsphbo_cHNIOhWxATIf7J3sY130_assertion evidence source_evidence_literature NP308867.RAd8ookVKkZ6ryCNFBUcAIsphbo_cHNIOhWxATIf7J3sY130_provenance.
- NP308867.RAd8ookVKkZ6ryCNFBUcAIsphbo_cHNIOhWxATIf7J3sY130_assertion SIO_000772 10805278 NP308867.RAd8ookVKkZ6ryCNFBUcAIsphbo_cHNIOhWxATIf7J3sY130_provenance.
- NP308867.RAd8ookVKkZ6ryCNFBUcAIsphbo_cHNIOhWxATIf7J3sY130_assertion wasDerivedFrom befree-20140225 NP308867.RAd8ookVKkZ6ryCNFBUcAIsphbo_cHNIOhWxATIf7J3sY130_provenance.
- NP308867.RAd8ookVKkZ6ryCNFBUcAIsphbo_cHNIOhWxATIf7J3sY130_assertion wasGeneratedBy ECO_0000203 NP308867.RAd8ookVKkZ6ryCNFBUcAIsphbo_cHNIOhWxATIf7J3sY130_provenance.
- befree-20140225 importedOn "2014-02-25" NP308867.RAd8ookVKkZ6ryCNFBUcAIsphbo_cHNIOhWxATIf7J3sY130_provenance.